Episode 97
🧬Chris Moxham - Transcripta Bio - Part 4 | Partnership Strategies with Big Pharma | Balancing Science & Business | Leveraging AI in Drug Discovery | The Vision for Transcripta Bio
Part 4 of 4: Jon Chee hosts Chris Moxham, Co-Founder, CEO, and CSO of Transcripta Bio—a pioneering biotech company accelerating drug discovery to improve lives worldwide. With a PhD in Molecular and Cellular Pharmacology from Stony Brook University and over 25 years in drug discovery, Chris brings a wealth of experience. During his two-decade tenure at Eli Lilly, he advanced over 10 molecules into clinical trials across multiple therapeutic areas, spanning both small and large molecule modalities. Chris’s deep expertise and dedication to scientific innovation and team development offer invaluable insights for aspiring biotech leaders.
The Biotech Startups Podcast · Excedr
November 21, 202426m 31s
Audio is streamed directly from the publisher (media.fame.so) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Part 4 of 4: Jon Chee hosts Chris Moxham, Co-Founder, CEO, and CSO of Transcripta Bio—a pioneering biotech company accelerating drug discovery to improve lives worldwide.
With a PhD in Molecular and Cellular Pharmacology from Stony Brook University and over 25 years in drug discovery, Chris brings a wealth of experience. During his two-decade tenure at Eli Lilly, he advanced over 10 molecules into clinical trials across multiple therapeutic areas, spanning both small and large molecule modalities.
Chris’s deep expertise and dedication to scientific innovation and team development offer invaluable insights for aspiring biotech leaders.
Join us this week to hear about:
- The complexities of building partnerships with Big Pharma as a startup
- Insights on developing relationships with larger organizations and patient foundations
- The importance of mutual goals and the art of aligning incentives
- Transcripta’s progress with their groundbreaking Drug-Gene Atlas, combining genetics, AI, and high-throughput data to redefine the future of drug discovery
Please enjoy Jon’s conversation with Chris Moxham.
Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994
Find Our Guest, Chris Moxham, at these links:
Find Our Host, Jon Chee, at these links:
Excedr Socials & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Enriched Notes:
Topics Mentioned:
Eli Lilly & Company: https://www.lilly.com/
Transcripta Bio: https://www.transcriptabio.com/
Fulcrum Therapeutics: https://www.fulcrumtx.com/
NVIDIA: https://www.nvidia.com/en-us/
Biotech Partnerships with Big Pharma: https://www.excedr.com/blog/how-biotech-partnerships-support-research
The Role of BD in the Life Sciences: https://www.excedr.com/resources/business-development-in-the-life-sciences
How to Break into Biotech BD: https://www.excedr.com/blog/how-to-break-into-biotech-bd-as-a-phd-student
Drug-Gene Atlas: https://www.transcriptabio.com/what-we-do
Biotech Startup Support: https://www.excedr.com/resources-category/biotech-startup-support
People Mentioned:
Efraim Racker: https://efraimracker.library.cornell.edu/
Craig Malbon: https://www.pharm.stonybrook.edu/faculty/m/malbon
John Hadcock: https://www.linkedin.com/in/hadcock/
Alan Palkowitz: https://www.linkedin.com/in/alan-palkowitz-7387653/
Phil Hipskin: https://www.linkedin.com/in/philip-hipskind-a3b11611/
Greg Plowman: https://www.linkedin.com/in/greg-plowman-4177096/
Robert Gould: https://www.linkedin.com/in/robertjgouldfulcrum/
Jim Collins: https://be.mit.edu/faculty/james-j-collins/
Jim Geraghty: https://www.linkedin.com/in/jim-geraghty-7481a262/
Alan Ezekowitz: https://www.linkedin.com/in/alan-ezekowitz-54030515/
Timestamps:
00:00 Intro and recap
02:09 Partnering with Big Pharma and the urgency of startups
04:13 Learning business development and building successful partnerships
06:18 Understanding stakeholder involvement and approval layers in Big Pharma
09:42 Transcripta's collaborations with patient foundations and medical institutions
11:31 Ideal partnerships with academic institutions and aligning incentives
15:53 The importance of partnership alignment, building trust within the org
20:47 Transcripta Bio's vision for the future
21:52 Shoutouts and advice to younger self
24:45 Outro
The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.